Can we eliminate severe ovarian hyperstimulation syndrome?

被引:72
作者
Orvieto, R [1 ]
机构
[1] Rabin Med Ctr, Dept Obstet & Gynecol, IL-49100 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
controlled ovarian stimulation; ovarian hyperstimulation syndrome; prevention;
D O I
10.1093/humrep/deh613
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The desire of some couples for children is so strong that they are willing to accept a modicum of risk to treat their infertility. Ideally, assisted reproduction technology practitioners seek a balance between optimum ovarian stimulation and successful treatment outcome with minimal rate of severe ovarian hyperstimulation syndrome (OHSS) or multiple pregnancies. However, despite many years of clinical experience, there are no precise methods to completely prevent severe OHSS, except by withholding the ovulation-inducing trigger of hCG. Individualization of treatment according to the specific risk factor and the specific response in the current cycle with the option of freezing of all embryos, or replacement of only a single embryo, has the potential of reducing the risk and the severity of the syndrome in susceptible cases. We offer a triage aimed at eliminating the occurrence of severe ovarian hyperstimulation syndrome on the basis of several clinical observations, including the role of GnRH antagonist in controlled ovarian stimulation protocols, the option of freezing of all embryos, or replacement of only a single embryo in the blastocyst stage.
引用
收藏
页码:320 / 322
页数:3
相关论文
共 19 条
[1]   SEVERE OVARIAN HYPERSTIMULATION SYNDROME IN ASSISTED REPRODUCTIVE TECHNOLOGY - DEFINITION OF HIGH-RISK GROUPS [J].
ASCH, RH ;
LI, HP ;
BALMACEDA, JP ;
WECKSTEIN, LN ;
STONE, SC .
HUMAN REPRODUCTION, 1991, 6 (10) :1395-1399
[2]   TRIGGERING OF OVULATION BY A GONADOTROPIN-RELEASING-HORMONE AGONIST IN GONADOTROPIN-STIMULATED CYCLES FOR PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME AND MULTIPLE PREGNANCY [J].
BALASCH, J ;
TUR, R ;
CREUS, M ;
BUXADERAS, R ;
FABREGUES, F ;
BALLESCA, JL ;
BARRI, PN ;
VANRELL, JA .
GYNECOLOGICAL ENDOCRINOLOGY, 1994, 8 (01) :7-12
[3]  
BLANKSTEIN J, 1987, FERTIL STERIL, V47, P597
[4]   Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review [J].
Delvigne, A ;
Rozenberg, S .
HUMAN REPRODUCTION UPDATE, 2002, 8 (06) :559-577
[5]   SUCCESSFUL TREATMENT OF INFERTILE WOMEN WITH OLIGOMENORRHEA USING A COMBINATION OF AN LHRH AGONIST AND EXOGENOUS GONADOTROPINS [J].
FLEMING, R ;
HAXTON, MJ ;
HAMILTON, MPR ;
MCCUNE, GS ;
BLACK, WP ;
MACNAUGHTON, MC ;
COUTTS, JRT .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1985, 92 (04) :369-373
[6]  
FORMAN RG, 1990, FERTIL STERIL, V53, P502
[7]  
HANCOCK KW, 1970, LANCET, V2, P482
[8]   Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome [J].
Kol, S .
FERTILITY AND STERILITY, 2004, 81 (01) :1-5
[9]  
Levy T, 1996, HUM REPROD, V11, P1177
[10]  
LYONS CAD, 1994, HUM REPROD, V9, P792